MeSH tree: C04.588.894.797.520
A new study led by researchers at the American Cancer Society (ACS) shows that the overall five-year cancer survival rates for each stage of cancer (localized, regional, distant) were lower in non-metropolitan areas for Black ...
Sep 25, 2025
0
23
About 5% of lung adenocarcinomas, one of the most common forms of lung cancer, are driven by a faulty fusion of two genes, EML4 and ALK. This fusion results in different variants, and until now, clinicians have treated all ...
Sep 23, 2025
0
15
A new study reveals that small cell lung cancer (SCLC) likely begins in basal stem-like cells rather than in neuroendocrine cells, marking a major shift in the understanding of this aggressive disease that is often associated ...
Sep 17, 2025
0
14
A study published in JCO Clinical Cancer Informatics demonstrates that machine learning models incorporating patient-reported outcomes and wearable sensor data can predict which patients with non–small cell lung cancer are ...
Sep 15, 2025
0
14
An international research team has shown that lung cancer cells can form functional synapses with neurons, effectively hijacking the body's neural circuits to grow faster. The finding reveals a startling new dimension of ...
Sep 10, 2025
0
35
Small cell lung cancer cells that metastasize to the brain cozy up to neurons and form working electrical connections, called synapses, according to a study led by Stanford Medicine researchers. The pulse of electrical signals ...
Sep 10, 2025
0
52
Lung cancer patients who take medications called GLP-1 receptor agonists—commonly prescribed for weight loss and diabetes management—fare better than those who don't, according to research led by Sai Yendamuri, MD, MBA, FACS, ...
Sep 9, 2025
0
12
In a move that could reshape drug discovery, researchers at Harvard Medical School have designed an artificial intelligence model capable of identifying treatments that reverse disease states in cells.
Sep 9, 2025
0
28
New research presented identifies interferon-induced transmembrane protein 3 (IFITM3) as a critical regulator of immunotherapy sensitivity in small cell lung cancer (SCLC), offering a promising new avenue for overcoming resistance ...
Sep 9, 2025
0
14
A new study presented reports encouraging long-term survival outcomes from an experimental viral immunotherapy, CAN-2409, in patients with advanced non-small cell lung cancer (NSCLC) who previously failed to respond adequately ...
Sep 9, 2025
0
15
